2022 International Big Health Industry Expo was held

The reporter was informed that from July 13th to 16th, the "2022 International Health Industry (Chongqing) Expo (Seventh Double Exchange)" was held in Chongqing. Invited to the meeting, jointly interpret policies and opportunities, and share new concepts, new technologies, and new achievements in the development of the industry. The new Chinese medicine Lianhua Qingjuan won the "Product Leading Award" issued by the Expo.

At the Shuangpinhui "2022 International Big Health Brand Summit Forum", the company representatives shared the latest research results of Lianhua Qingjuan and played a positive leading role in the field of pharmaceutical health at home and abroad, which has aroused strong attention from the guests.

Lianhua Qing Plague is a patented innovation Chinese medicine developed under the guidance of the theory of Chinese medicine in Ling Pharmaceutical. Since its listing in 2005, it has been included in the National Health and Health Commission and the State Administration of Traditional Chinese Medicine. The representative Chinese medicine, "Research on Chinese Medicine Lianhua Qing Plague in the treatment of popular colds" won the second prize of national science and technology progress in 2011.

- END -